Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Optimization Of Extended Pelvic Lymph Node Dissection Side For Prostate Cancer.
  1. Home
  3. Optimization Of Extended Pelvic Lymph Node Dissection Side For Prostate Cancer.

Related Experiment Video

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.6K

Optimization of Extended Pelvic Lymph Node Dissection Side for Prostate Cancer.

Masaki Shiota1, Masaki Shimbo2, Shigehiro Tsukahara3

  • 1Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. shiota.masaki.101@m.kyushu-u.ac.jp.

Annals of Surgical Oncology
|September 28, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

This study shows tumor location-guided extended pelvic lymph node dissection (ePLND) accurately detects positive lymph nodes in prostate cancer. This approach optimizes unilateral ePLND, potentially reducing the need for bilateral procedures.

Keywords:
Extended pelvic lymph node dissectionLateralityLymph node involvementRadical prostatectomyTumor location

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

7.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K

Related Experiment Videos

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.6K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

7.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K

Area of Science:

  • Urology
  • Oncology
  • Surgical Oncology

Background:

  • Prostate cancer staging relies on accurate lymph node assessment.
  • Extended pelvic lymph node dissection (ePLND) is crucial for staging but can be bilateral.
  • Optimizing ePLND side selection can improve patient outcomes and reduce morbidity.

Purpose of the Study:

  • To determine the association between prostate tumor location and the laterality of positive lymph nodes.
  • To evaluate the efficacy of tumor location-guided extended pelvic lymph node dissection (ePLND).
  • To optimize unilateral ePLND for prostate cancer management.

Main Methods:

  • Retrospective analysis of patients undergoing robot-assisted radical prostatectomy with ePLND.
  • Tumor localization using biopsy and magnetic resonance imaging (MRI) findings.
  • Evaluation of tumor location-guided unilateral ePLND for positive lymph node detection accuracy.

    • Main Results:

    • Tumor locations were unilateral in 74.1% and bilateral in 23.3% of 301 patients.
    • Tumor location-guided unilateral ePLND achieved 99.6% accuracy for detecting any positive lymph nodes.
    • High accuracies (99.0% and 97.3%) were observed in independent patient cohorts.

    Conclusions:

    • Tumor location-guided ePLND is a viable strategy for prostate cancer.
    • This approach enables optimized unilateral ePLND, reducing surgical burden.
    • Acceptable risk of missing positive lymph nodes may be balanced against reduced bilateral dissection.